Brief: India's Nectar Life Sciences March-Quarter Consol Profit From Continuing Operations Falls
26/05/2023 09:10
May 26 (Reuters) - Nectar Lifesciences Ltd NECT.NS :
* MARCH-QUARTER CONSOL PROFIT FROM CONTINUING OPERATIONS
36.8
MILLION RUPEES VERSUS 116.6 MILLION RUPEES
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.88 BILLION
RUPEES
VERSUS 4.76 BILLION RUPEES
Source text for Eikon: ID:nBSE1Vq5DQ
Further company coverage: NECT.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nectar Lifesciences
See all newsBrief: Nectar Lifesciences To Acquire 100% Paid- Up Equity Share Capital Of Avensis Exports
Brief: Nectar Lifesciences Approves Buyback Of Shares Valued At 810 Million Rupees
India's Nectar Lifesciences jumps on plan to consider buyback of shares
Brief: Nectar Lifesciences Proposes Buyback Of Equity Shares
Brief: Nectar Lifesciences Says Secured Debt And Interest Owed By Co Fully Repaid And Settled With Banks